S.Y. Bancorp Aktie - SYI

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Premium

Current Price

Gebot

Fragen

Volumen

0,00 Tagesbereich 0,00

0,00 52-Wochen-Bereich 0,00

Handelsende

Handelsbeginn

Letzte Trade

Letzter Handelszeitpunkt

Durchschnittliches Volumen (3 Mio.)

Finanzvolumen

VWAP

Synvista Therapeutics Announces Restructuring of Dividend Obligation to Preferred Stockholders and Decision to Delist from NYSE

MONTVALE, N.J., Feb. 24 /PRNewswire-FirstCall/ -- Synvista Therapeutics, Inc. (NYSE Alternext US: SYI) today announced that it has entered into...

Synvista Therapeutics Announces Termination of Clinical Trials of Alagebrium and SYI-2074 and Provides Business Update

MONTVALE, N.J., Jan. 28 /PRNewswire-FirstCall/ -- Synvista Therapeutics, Inc. (NYSE Alternext US: SYI) today announced that, following a review...

Synvista Therapeutics Announces Progress in Phase 2 Clinical Trial Program for Alagebrium

MONTVALE, N.J., Jan. 12 /PRNewswire-FirstCall/ -- Synvista Therapeutics, Inc. (NYSE Alternext US: SYI) has completed enrollment of its...

Synvista Notified by NYSE Alternext of Continued Listing Standards Non-Compliance

Company Expects Its Common Stock to Remain Listed While it Engages in Compliance Process MONTVALE, N.J., Dec. 24 /PRNewswire-FirstCall/...

Synvista Therapeutics Announces Published Data Demonstrating Elevation of Carboxymethyl-Lysine (CML) Is Associated with Decline

Synvista Therapeutics Technology Provided CML Biomarker Data for Studies MONTVALE, N.J., Dec. 16 /PRNewswire-FirstCall/ -- Synvista...

Synvista Therapeutics Announces First Dosing of SYI-2074 in Clinical Trial for Psoriasis

MONTVALE, N.J., Dec. 15 /PRNewswire-FirstCall/ -- Synvista Therapeutics, Inc. (NYSE Alternext US: SYI) has dosed the first patient in a...

Synvista Therapeutics Announces 510(k) Submission for Its HAPTOCHEK(TM) Test Kit

MONTVALE, N.J., Nov. 19 /PRNewswire-FirstCall/ -- Synvista Therapeutics, Inc. (AMEX:SYI) today announced that it has submitted, and that the FDA...

Synvista Therapeutics Announces Data Further Demonstrating the Value of Haptoglobin Genotyping in Diabetic Patients During AHA M

New Data Presented at the Meeting Demonstrate Vitamin E May Help Prevent Cardiovascular Events in Hp2-2 Diabetes MONTVALE, N.J., Nov. 11...

Synvista Therapeutics to Present at the Rodman & Renshaw 10th Annual Healthcare Conference

- Presentation to be Webcast - MONTVALE, N.J. , Nov. 10 /PRNewswire-FirstCall/ -- Synvista Therapeutics, Inc. (AMEX:SYI) announced today that...

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

SYI - Frequently Asked Questions (FAQ)

What is the current S.Y. Bancorp share price?

The current share price of S.Y. Bancorp is US$ 0,00

What is the 1 year trading range for S.Y. Bancorp share price?

S.Y. Bancorp has traded in the range of US$ 0,00 to US$ 0,00 during the past year

Volumen
% Tops
% Flops

Symbol	Preis	Vol.
GENCGencor Industries Inc	US$ 16,00 (20,12%)	10
ROLRHigh Roller Technologies Inc	US$ 4,83 (19,55%)	7
EUADSelect STOXX Europe Aerospace and Defense ETF	US$ 32,00 (14,77%)	17
ECFEllsworth Growth and Income Fund Ltd	US$ 11,37 (13,25%)	2
COE51Talk Online Education Group	US$ 23,99 (13,16%)	17
XDECFT Vest US Equity Enhance & Moderate Buffer ETF December	US$ 31,00 (-18,36%)	1
LODEComstock Inc	US$ 0,31 (-11,81%)	220,06k
ACCSACCESS Newswire Inc	US$ 9,51 (-11,30%)	9
SOARVolato Group Inc	US$ 0,17 (-9,43%)	47,08k
GMARFT Vest US Equity Moderate Buffer ETF March	US$ 35,00 (-8,66%)	9
ETHU2x Ether ETF	US$ 4,37 (-3,32%)	1,9M
SOXLDirexion Daily Semiconductor Bull 3X Shares	US$ 29,20 (2,28%)	1,05M
TSLZT Rex 2X Inverse Tesla Daily Target ETF	US$ 2,81 (-1,92%)	944,12k
FXIiShares China Large Cap	US$ 35,61 (1,63%)	705,81k
YINNDirexion Daily FTSE China Bull 3X Shares	US$ 42,76 (4,73%)	675,55k

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Synvista Therapeutics, (SYI)

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Wichtige Statistiken und Details

SYI Neueste Nachrichten

Synvista Therapeutics Announces Restructuring of Dividend Obligation to Preferred Stockholders and Decision to Delist from NYSE

Synvista Therapeutics Announces Termination of Clinical Trials of Alagebrium and SYI-2074 and Provides Business Update

Synvista Therapeutics Announces Progress in Phase 2 Clinical Trial Program for Alagebrium

Synvista Notified by NYSE Alternext of Continued Listing Standards Non-Compliance

Synvista Therapeutics Announces Published Data Demonstrating Elevation of Carboxymethyl-Lysine (CML) Is Associated with Decline

Synvista Therapeutics Announces First Dosing of SYI-2074 in Clinical Trial for Psoriasis

Synvista Therapeutics Announces 510(k) Submission for Its HAPTOCHEK(TM) Test Kit

Synvista Therapeutics Announces Data Further Demonstrating the Value of Haptoglobin Genotyping in Diabetic Patients During AHA M

Synvista Therapeutics to Present at the Rodman & Renshaw 10th Annual Healthcare Conference

SYI - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Synvista Therapeutics, (SYI) Börsenkurse

Synvista Therapeutics, (SYI)

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Wichtige Statistiken und Details

SYI Neueste Nachrichten

Synvista Therapeutics Announces Restructuring of Dividend Obligation to Preferred Stockholders and Decision to Delist from NYSE

Synvista Therapeutics Announces Termination of Clinical Trials of Alagebrium and SYI-2074 and Provides Business Update

Synvista Therapeutics Announces Progress in Phase 2 Clinical Trial Program for Alagebrium

Synvista Notified by NYSE Alternext of Continued Listing Standards Non-Compliance

Synvista Therapeutics Announces Published Data Demonstrating Elevation of Carboxymethyl-Lysine (CML) Is Associated with Decline

Synvista Therapeutics Announces First Dosing of SYI-2074 in Clinical Trial for Psoriasis

Synvista Therapeutics Announces 510(k) Submission for Its HAPTOCHEK(TM) Test Kit

Synvista Therapeutics Announces Data Further Demonstrating the Value of Haptoglobin Genotyping in Diabetic Patients During AHA M

Synvista Therapeutics to Present at the Rodman & Renshaw 10th Annual Healthcare Conference

SYI - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Werbung entfernen

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE